drugset / Trial / NCT00570284

A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors

NCT00570284

Phase 1 Completed 36 enrolled Novartis Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of this study is to evaluate the effect of food on oral LBH589 in adult patients with advanced solid tumors. This study will also evaluate the safety and efficacy of LBH589 in adult patients with advanced solid tumors

Timeline

Start
2007-11
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Panobinostat Small molecule 20 mg Oral
Subject Panobinostat Small molecule 45 mg Oral

Indications